From: Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy
Species
CL (mL/min/kg)
Vss (L/kg)
t1/2 (h)
F (%)
AUC (ng h/mL)
Rat
3.7
0.639
2.42
94.0
6940
Dog
24.3
0.957
0.840
18.6
237
Human
0.64
1.1
19
64
ND